Justin Leong - 14 Aug 2026 Form 4 Insider Report for RESMED INC (RMD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 Oct 2026, 16:27:25 UTC
Prior SEC filing
24 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Julie Hutt, attorney-in-fact for Justin Leong

Key filing fact

Justin Leong filed Form 4 for RESMED INC (RMD) on 01 Oct 2026.

Key facts

  • This page summarizes Justin Leong's Form 4 filing for RESMED INC (RMD).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 01 Oct 2026, 16:27.

Change

  • Previous filing in this sequence was filed on 24 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001825782 Primary reporting owner

Leong Justin

Relationship
Chief Product Officer
Address
9001 SPECTRUM CENTER BLVD, SAN DIEGO
Signature
/s/ Julie Hutt, attorney-in-fact for Justin Leong
Signature date
01 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMD transaction

ResMed Common Stock

Award

Transaction value
Shares
+6,461
Change %
+22%
Price
$0.000000*
Shares after
35,489
Date
14 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents performance-based restricted stock units granted on November 20, 2025. The RSUs were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met. RSUs vest 1/3 each year on the anniversary of the grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .